Moist Exposed Burn Ointment (MEBO)	placebo	wound surface area (WSA)	12394	12557	After 2 months of treatment, these changes were −6.0 (−8.8, −3.3), −2.6 (−4.7, −1.5), and −2.9 (−4.4, −1.7), respectively, between the 2 groups (P < .01; Table 2).
Moist Exposed Burn Ointment (MEBO)	placebo	pressure ulcer scale for healing (PUSH) tool	12394	12557	After 2 months of treatment, these changes were −6.0 (−8.8, −3.3), −2.6 (−4.7, −1.5), and −2.9 (−4.4, −1.7), respectively, between the 2 groups (P < .01; Table 2).
Moist Exposed Burn Ointment (MEBO)	placebo	healing status of pressure ulcers	12658	12856	Analysis of the healing status of pressure ulcers after 2 months found that ulcers in 50.0% of patients in the MEBO group and 16.7% of those in the placebo group underwent completely healed (P < .05
Moist Exposed Burn Ointment (MEBO)	placebo	adverse effects	12868	12944	In addition, no patients in the 2 groups reported any major adverse effects.
Moist Exposed Burn Ointment (MEBO)	placebo	healing status of pressure ulcers	12658	12867	Analysis of the healing status of pressure ulcers after 2 months found that ulcers in 50.0% of patients in the MEBO group and 16.7% of those in the placebo group underwent completely healed (P < .05; Table 3).
Moist Exposed Burn Ointment (MEBO)	placebo	adverse effects	12881	12944	no patients in the 2 groups reported any major adverse effects.
